HEADER TRANSFERASE 13-APR-20 6YNA TITLE CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX TITLE 2 WITH FASUDIL (M77, SOAKED) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: PKI-ALPHA,CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 11 MUSCLE/BRAIN ISOFORM; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRICETULUS GRISEUS; SOURCE 3 ORGANISM_COMMON: CHINESE HAMSTER; SOURCE 4 ORGANISM_TAXID: 10029; SOURCE 5 GENE: PRKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 11 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 12 ORGANISM_TAXID: 10090 KEYWDS PHOSPHOTRANSFERASE, SIGNALLING PATHWAYS, GLYCOGEN METABOLISM, KEYWDS 2 SERINE/THREONINE KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.OEBBEKE,B.WIENEN-SCHMIDT,A.HEINE,G.KLEBE REVDAT 5 06-NOV-24 6YNA 1 REMARK REVDAT 4 24-JAN-24 6YNA 1 REMARK REVDAT 3 20-JAN-21 6YNA 1 JRNL REVDAT 2 21-OCT-20 6YNA 1 JRNL REVDAT 1 14-OCT-20 6YNA 0 JRNL AUTH B.WIENEN-SCHMIDT,M.OEBBEKE,K.NGO,A.HEINE,G.KLEBE JRNL TITL TWO METHODS, ONE GOAL: STRUCTURAL DIFFERENCES BETWEEN JRNL TITL 2 COCRYSTALLIZATION AND CRYSTAL SOAKING TO DISCOVER LIGAND JRNL TITL 3 BINDING POSES. JRNL REF CHEMMEDCHEM V. 16 292 2021 JRNL REFN ESSN 1860-7187 JRNL PMID 33029876 JRNL DOI 10.1002/CMDC.202000565 REMARK 2 REMARK 2 RESOLUTION. 1.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.85 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 79451 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3972 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.8500 - 4.4600 1.00 2916 153 0.1789 0.2141 REMARK 3 2 4.4500 - 3.5400 1.00 2788 147 0.1630 0.1751 REMARK 3 3 3.5400 - 3.0900 1.00 2757 145 0.1782 0.1964 REMARK 3 4 3.0900 - 2.8100 1.00 2729 144 0.1835 0.1904 REMARK 3 5 2.8100 - 2.6100 1.00 2734 143 0.1773 0.2076 REMARK 3 6 2.6100 - 2.4500 1.00 2715 143 0.1699 0.1739 REMARK 3 7 2.4500 - 2.3300 1.00 2698 142 0.1592 0.1914 REMARK 3 8 2.3300 - 2.2300 1.00 2723 144 0.1575 0.2174 REMARK 3 9 2.2300 - 2.1400 1.00 2690 141 0.1606 0.1822 REMARK 3 10 2.1400 - 2.0700 1.00 2701 142 0.1577 0.1607 REMARK 3 11 2.0700 - 2.0000 1.00 2726 144 0.1611 0.1802 REMARK 3 12 2.0000 - 1.9500 1.00 2655 140 0.1475 0.1793 REMARK 3 13 1.9500 - 1.9000 1.00 2707 142 0.1503 0.1735 REMARK 3 14 1.9000 - 1.8500 1.00 2690 142 0.1382 0.1705 REMARK 3 15 1.8500 - 1.8100 1.00 2679 141 0.1361 0.1587 REMARK 3 16 1.8100 - 1.7700 1.00 2646 139 0.1280 0.1647 REMARK 3 17 1.7700 - 1.7300 1.00 2716 143 0.1271 0.1607 REMARK 3 18 1.7300 - 1.7000 1.00 2666 140 0.1283 0.1669 REMARK 3 19 1.7000 - 1.6700 1.00 2676 141 0.1354 0.1906 REMARK 3 20 1.6700 - 1.6400 1.00 2700 142 0.1421 0.1833 REMARK 3 21 1.6400 - 1.6200 1.00 2646 139 0.1389 0.2130 REMARK 3 22 1.6200 - 1.5900 1.00 2681 142 0.1445 0.1744 REMARK 3 23 1.5900 - 1.5700 1.00 2669 140 0.1436 0.2166 REMARK 3 24 1.5700 - 1.5500 1.00 2660 140 0.1512 0.1851 REMARK 3 25 1.5500 - 1.5200 1.00 2660 140 0.1465 0.1692 REMARK 3 26 1.5200 - 1.5000 1.00 2670 140 0.1549 0.2271 REMARK 3 27 1.5000 - 1.4900 1.00 2687 142 0.1692 0.2031 REMARK 3 28 1.4900 - 1.4700 0.93 2494 131 0.1924 0.2458 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.125 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.165 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.07 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 3079 REMARK 3 ANGLE : 0.775 4200 REMARK 3 CHIRALITY : 0.073 448 REMARK 3 PLANARITY : 0.005 556 REMARK 3 DIHEDRAL : 21.420 1116 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YNA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-APR-20. REMARK 100 THE DEPOSITION ID IS D_1292107489. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918409 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 79455 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.468 REMARK 200 RESOLUTION RANGE LOW (A) : 45.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03500 REMARK 200 FOR THE DATA SET : 27.5900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.56 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.47800 REMARK 200 FOR SHELL : 3.790 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1Q8W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.24MM PKA, 30MM MES-BIS-TRIS-BUFFER REMARK 280 PH 6.2-6.9, 1MM DTT, 0.1MM EDTA, 75MM LICL, 0.3MM MEGA 8, 0.7MM REMARK 280 PKI, 16%(V/V) METHANOL; SOAKING IN BUFFER DESCRIBED WITH 0.12MM REMARK 280 LIGAND SOLVED IN DMSO AND 30%(V/V) MPD, PH 6.9, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.15650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.51950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.27350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.51950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.15650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.27350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE B 11 REMARK 465 ALA B 12 REMARK 465 LEU B 26 REMARK 465 VAL B 27 REMARK 465 ALA B 28 REMARK 465 ALA B 29 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 2 CG OD1 ND2 REMARK 470 LYS A 7 CG CD CE NZ REMARK 470 LYS A 8 NZ REMARK 470 LYS A 21 NZ REMARK 470 GLU A 24 CD OE1 OE2 REMARK 470 LYS A 28 CD CE NZ REMARK 470 LYS A 29 CE NZ REMARK 470 SER A 32 OG REMARK 470 SER A 34 OG REMARK 470 GLN A 35 CG CD OE1 NE2 REMARK 470 ASN A 36 CG OD1 ND2 REMARK 470 PHE A 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 61 CE NZ REMARK 470 GLU A 64 CG CD OE1 OE2 REMARK 470 ASP A 75 CG OD1 OD2 REMARK 470 GLN A 77 CG CD OE1 NE2 REMARK 470 LYS A 78 CG CD CE NZ REMARK 470 VAL A 80 CG1 REMARK 470 LYS A 81 CG CD CE NZ REMARK 470 LEU A 82 CG CD1 CD2 REMARK 470 LYS A 83 CG CD CE NZ REMARK 470 GLN A 176 CG CD OE1 NE2 REMARK 470 LYS A 254 CG CD CE NZ REMARK 470 ARG A 256 CZ NH1 NH2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 295 CG CD CE NZ REMARK 470 LYS A 317 CD CE NZ REMARK 470 PHE A 318 CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 319 CG CD CE NZ REMARK 470 GLU A 331 CG CD OE1 OE2 REMARK 470 GLU A 333 CG CD OE1 OE2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 ILE A 335 CG1 CG2 CD1 REMARK 470 ARG A 336 CG CD NE CZ NH1 NH2 REMARK 470 VAL A 337 CG1 REMARK 470 ILE A 339 CG1 CG2 CD1 REMARK 470 ASN A 340 CG OD1 ND2 REMARK 470 LYS A 342 CG CD CE NZ REMARK 470 LYS A 345 CG CD CE NZ REMARK 470 GLU A 349 CG CD OE1 OE2 REMARK 470 GLN B 20 CG CD OE1 NE2 REMARK 470 HIS B 23 CG ND1 CD2 CE1 NE2 REMARK 470 ILE B 25 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 46 -61.01 -105.78 REMARK 500 ASP A 166 41.85 -149.47 REMARK 500 ASP A 184 78.66 63.19 REMARK 500 ASP A 184 78.66 67.28 REMARK 500 ASN A 216 -167.05 -129.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 121 DISTANCE = 6.97 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M77 A 402 DBREF 6YNA A 0 350 UNP P25321 KAPCA_CRIGR 1 351 DBREF 6YNA B 11 29 UNP P63248 IPKA_MOUSE 12 30 SEQADV 6YNA GLY A -2 UNP P25321 EXPRESSION TAG SEQADV 6YNA HIS A -1 UNP P25321 EXPRESSION TAG SEQADV 6YNA ALA B 13 UNP P63248 SER 14 ENGINEERED MUTATION SEQADV 6YNA GLN B 20 UNP P63248 ASN 21 ENGINEERED MUTATION SEQADV 6YNA ALA B 28 UNP P63248 SER 29 ENGINEERED MUTATION SEQADV 6YNA ALA B 29 UNP P63248 SER 30 ENGINEERED MUTATION SEQRES 1 A 353 GLY HIS MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SEP SEQRES 2 A 353 GLU GLN GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS SEQRES 3 A 353 GLU GLU PHE LEU LYS LYS TRP GLU SER PRO SER GLN ASN SEQRES 4 A 353 THR ALA GLN LEU ASP HIS PHE ASP ARG ILE LYS THR LEU SEQRES 5 A 353 GLY THR GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS SEQRES 6 A 353 LYS GLU THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP SEQRES 7 A 353 LYS GLN LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR SEQRES 8 A 353 LEU ASN GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO SEQRES 9 A 353 PHE LEU VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER SEQRES 10 A 353 ASN LEU TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU SEQRES 11 A 353 MET PHE SER HIS LEU ARG ARG ILE GLY ARG PHE SEP GLU SEQRES 12 A 353 PRO HIS ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR SEQRES 13 A 353 PHE GLU TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP SEQRES 14 A 353 LEU LYS PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR SEQRES 15 A 353 ILE GLN VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS SEQRES 16 A 353 GLY ARG THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU SEQRES 17 A 353 ALA PRO GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA SEQRES 18 A 353 VAL ASP TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET SEQRES 19 A 353 ALA ALA GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE SEQRES 20 A 353 GLN ILE TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE SEQRES 21 A 353 PRO SER HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG SEQRES 22 A 353 ASN LEU LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN SEQRES 23 A 353 LEU LYS ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP SEQRES 24 A 353 PHE ALA THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS SEQRES 25 A 353 VAL GLU ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY SEQRES 26 A 353 ASP THR SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE SEQRES 27 A 353 ARG VAL SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE THR SEQRES 28 A 353 GLU PHE SEQRES 1 B 19 ILE ALA ALA GLY ARG THR GLY ARG ARG GLN ALA ILE HIS SEQRES 2 B 19 ASP ILE LEU VAL ALA ALA MODRES 6YNA SEP A 10 SER MODIFIED RESIDUE MODRES 6YNA SEP A 139 SER MODIFIED RESIDUE MODRES 6YNA TPO A 197 THR MODIFIED RESIDUE MODRES 6YNA SEP A 338 SER MODIFIED RESIDUE HET SEP A 10 10 HET SEP A 139 10 HET TPO A 197 11 HET SEP A 338 10 HET MPD A 401 8 HET M77 A 402 20 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM M77 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE HETSYN M77 FASUDIL; (5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE FORMUL 1 SEP 3(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 MPD C6 H14 O2 FORMUL 4 M77 C14 H17 N3 O2 S FORMUL 5 HOH *306(H2 O) HELIX 1 AA1 GLY A 1 SER A 32 1 32 HELIX 2 AA2 GLN A 39 ASP A 41 5 3 HELIX 3 AA3 LYS A 76 LEU A 82 1 7 HELIX 4 AA4 GLN A 84 VAL A 98 1 15 HELIX 5 AA5 GLU A 127 GLY A 136 1 10 HELIX 6 AA6 SEP A 139 LEU A 160 1 22 HELIX 7 AA7 LYS A 168 GLU A 170 5 3 HELIX 8 AA8 THR A 201 LEU A 205 5 5 HELIX 9 AA9 ALA A 206 LEU A 211 1 6 HELIX 10 AB1 LYS A 217 GLY A 234 1 18 HELIX 11 AB2 GLN A 242 GLY A 253 1 12 HELIX 12 AB3 SER A 262 LEU A 273 1 12 HELIX 13 AB4 VAL A 288 ASN A 293 1 6 HELIX 14 AB5 HIS A 294 ALA A 298 5 5 HELIX 15 AB6 ASP A 301 GLN A 307 1 7 SHEET 1 AA1 5 PHE A 43 THR A 51 0 SHEET 2 AA1 5 GLY A 55 HIS A 62 -1 O LEU A 59 N LYS A 47 SHEET 3 AA1 5 HIS A 68 ASP A 75 -1 O MET A 71 N MET A 58 SHEET 4 AA1 5 ASN A 115 GLU A 121 -1 O MET A 120 N ALA A 70 SHEET 5 AA1 5 LEU A 106 LYS A 111 -1 N GLU A 107 O VAL A 119 SHEET 1 AA2 2 LEU A 162 ILE A 163 0 SHEET 2 AA2 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AA3 2 LEU A 172 ILE A 174 0 SHEET 2 AA3 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 LINK C GLY A 9 N SEP A 10 1555 1555 1.33 LINK C SEP A 10 N GLU A 11 1555 1555 1.33 LINK C PHE A 138 N SEP A 139 1555 1555 1.33 LINK C SEP A 139 N GLU A 140 1555 1555 1.33 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.33 SITE 1 AC1 8 VAL A 15 PHE A 18 PHE A 100 LEU A 152 SITE 2 AC1 8 GLU A 155 TYR A 306 HOH A 604 HOH A 650 SITE 1 AC2 15 LEU A 49 GLY A 50 THR A 51 VAL A 57 SITE 2 AC2 15 ALA A 70 GLU A 121 TYR A 122 VAL A 123 SITE 3 AC2 15 GLU A 127 GLU A 170 ASN A 171 LEU A 173 SITE 4 AC2 15 THR A 183 PHE A 327 HOH A 534 CRYST1 58.313 72.547 109.039 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017149 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013784 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009171 0.00000